These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Ly-6C+ natural T (NT) cells mediate immune surveillance against NK-sensitive and NK-resistant transplantable tumours in certain strains of mice. Martiniello R; Burton RC; Smart YC Int J Cancer; 1996 May; 66(4):532-7. PubMed ID: 8635870 [TBL] [Abstract][Full Text] [Related]
45. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms. Bean P; Mazumder A Immunobiology; 1992 Jun; 185(1):63-77. PubMed ID: 1398742 [TBL] [Abstract][Full Text] [Related]
46. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. Fletcher JM; Prentice HG; Grundy JE J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232 [TBL] [Abstract][Full Text] [Related]
47. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells. Lobo PI; Spencer CE J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268 [TBL] [Abstract][Full Text] [Related]
48. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes. Brooks CG; Holscher M J Immunol; 1987 Mar; 138(5):1331-7. PubMed ID: 3543127 [TBL] [Abstract][Full Text] [Related]
49. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F; Peri G; Villa A; Mantovani A J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624 [TBL] [Abstract][Full Text] [Related]
50. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing. Wiebke EA; Custer MC; Rosenberg SA; Lotze MT J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373 [TBL] [Abstract][Full Text] [Related]
52. [Natural killers and their physiological importance]. Malygin AM Tsitologiia; 1985 Oct; 27(10):1091-100. PubMed ID: 2416100 [TBL] [Abstract][Full Text] [Related]
53. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors. Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968 [TBL] [Abstract][Full Text] [Related]
54. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells. Stutman O; Lattime EC; Figarella EF Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250 [TBL] [Abstract][Full Text] [Related]
55. Tight conjugate formation is not always required for natural killer cell-mediated lysis. Smithson G; Wolcott RM; Chervenak R Cell Immunol; 1992 Nov; 145(1):30-42. PubMed ID: 1423644 [TBL] [Abstract][Full Text] [Related]
56. Segregation of the NK-sensitive phenotype in human x mouse somatic cell hybrids reveals separate genetic control of recognition and postrecognition determinants. Lauzon RJ; Roder JC Cell Immunol; 1985 Aug; 94(1):85-99. PubMed ID: 2990738 [TBL] [Abstract][Full Text] [Related]
57. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis. Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512 [TBL] [Abstract][Full Text] [Related]
58. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells. Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004 [TBL] [Abstract][Full Text] [Related]
59. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. Holmes KV; Welsh RM; Haspel MV J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198 [TBL] [Abstract][Full Text] [Related]
60. Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. Minato N; Bloom BR; Jones C; Holland J; Reid LM J Exp Med; 1979 May; 149(5):1117-33. PubMed ID: 221611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]